There was also significant difference between ductal carcinoma in situ (or with early infiltration) and invasive ductal carcinoma (P<0.05), and the former was weaker.
导管内癌（或伴早浸）与浸润性导管癌相比，表达水平低，差异有显著性意义（P<0.05）。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
应用推荐